Mark Enyedy - 02 Jun 2025 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Director
Signature
/s/ Mark Enyedy
Issuer symbol
CRL
Transactions as of
02 Jun 2025
Transactions value $
$408,901
Form type
4
Filing time
04 Jun 2025, 16:42:38 UTC
Previous filing
22 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Enyedy Mark J Director C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON /s/ Mark Enyedy 04 Jun 2025 0001586965

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $128K +946 $135.04 946 02 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $281K +2.08K $135.04 2.08K 02 Jun 2025 Common Stock 2.08K $135.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The unvested restricted stock units vest upon the earlier of 6/2/2026 or the business day prior to the Company's next annual meeting of shareholders.
F2 The stock options become exercisable upon the earlier of 6/2/2026 or the business day prior to the Company's next annual meeting of shareholders.